Client Description: Clinical-stage biopharmaceutical company specializing in rare pediatric and adult liver diseases. During the search, the company achieved its first EU and U.S. product approvals, emphasizing its rapid progress and critical need for advocacy leadership.
Objectives: Drive global patient advocacy efforts for rare disease treatments, with a focus on expanding access to medicine and improving patient outcomes. Lead initiatives to support diagnosis and treatment urgency, advance evidence generation, and build trust with the patient community.
Key Metrics:
- Days to first candidate presented: 6
- Candidates submitted: 7
- Days until offer accepted: 77